- Home
- IAE vs DRIO Comparison
IAE vs DRIO Comparison
Compare IAE & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IAE
Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | IAE | DRIO |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3M | 84.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IAE | DRIO |
|---|---|---|
| Price | $8.00 | $11.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 46.3K | 17.8K |
| Earning Date | 01-01-0001 | 03-09-2026 |
| Dividend Yield | ★ 10.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $24,732,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $5.31 | $5.94 |
| 52 Week High | $6.45 | $17.74 |
Technical Indicators
Market Signals| Indicator | IAE | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 50.64 |
| Support Level | $7.85 | $10.00 |
| Resistance Level | $8.25 | $11.77 |
| Average True Range (ATR) | 0.14 | 0.72 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 26.65 | 69.72 |
Price Performance
Historical ComparisonAbout IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.